Tag

Pharma 4.0

Why Your Digital Strategy May Be Incomplete: How Legacy Models Prevent End-To-End Digital Manufacturing
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Why Your Digital Strategy May Be Incomplete: How Legacy Models Prevent End-To-End Digital Manufacturing

 Why pharma organizations must diversify their digitization strategy, looking beyond legacy models that prevent complete, end-to-end digital manufacturing How a light, configurable MES can remove paper from production entirely and enable any-sized pharma company to fully utilize their MES across all lines and sites How a modern MES can digitally connect different data sources to close offline data gaps, improve data integrity and visibility, and unlock critical business intelligence — Marty Smyth SVP, Go-To-Market Strategy MasterControl As the senior vice president of go-to-market strategy, Marty Smyth is responsible market intelligence, product strategy, and bringing MasterControl quality and manufacturing products…

Continue reading
Panel Discussion: Pharma 4.0 – Biopharmaceutical Production in the Digital Age
LIFE SCIENCES, VIDEO

Panel Discussion: Pharma 4.0 – Biopharmaceutical Production in the Digital Age

Addressing the state of the biopharmaceutical industry today: Which emerging trend will see the most growth? Embracing modular automation, PAT and continuous processing to increase agility, flexibility and improve efficiencies People and technology: How are these forces working together to grow and mature our industry? IoT- how will cloud based data, data analytics and data integrity evolve compliance and quality towards continuous improvement How will these technologies affect patient and product needs towards more individualized therapies? — Moderator: Alison Moore is Senior Vice President, Process Development for Amgen serving both Operations and R&D organizations. She has held a number of…

Continue reading